Efficacy and Safety of Combination Therapy

2003102 citationsJournal Articlebronze Open Access

Authors

Philip Raskin · Southwestern Medical Center

Leslie J. Klaff · Rainier Clinical Research Center

Janet B. McGill · Washington University in St. Louis

Stephen A. South

Priscilla Hollander · Baylor University Medical Center

Naum Khutoryansky · Novo Nordisk (United States)

Paula M. Hale · Novo Nordisk (United States)

Abstract

The addition of repaglinide to metformin therapy resulted in reductions of HbA(1c) and FPG values that were significantly greater than the reductions observed for addition of nateglinide.

Topics & Keywords

Diabetes Treatment and Management Metabolism, Diabetes, and Cancer Diabetes Management and Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 26, Issue 7, pp. 2063-2068

DOI: 10.2337/diacare.26.7.2063

Field-Weighted Citation Impact: 5.23